<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39376205</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-6834</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Infection control and hospital epidemiology</Title><ISOAbbreviation>Infect Control Hosp Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Healthcare-associated infections in Japanese hospitals: results from a large-scale multicenter point-prevalence survey in Aichi, 2020.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>8</EndPage><MedlinePgn>1-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/ice.2024.130</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Healthcare-associated infections (HAIs) pose significant challenges to healthcare systems worldwide. Epidemiological data are essential for effective HAI control; however, comprehensive information on HAIs in Japanese hospitals is limited. This study aimed to provide an overview of HAIs in Japanese hospitals.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A multicenter point-prevalence survey (PPS) was conducted in 27 hospitals across the Aichi Prefecture between February and July 2020. This study encompassed diverse hospital types, including community, university, and specialized hospitals. Information on the demographic data of the patients, underlying conditions, devices, HAIs, and causative organisms was collected.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 10,199 patients (male: 5,460) were included in this study. The median age of the patients was 73 (interquartile range [IQR]: 56-82) years, and the median length of hospital stay was 10 (IQR: 4-22) days. HAIs were present in 6.6% of patients, with pneumonia (1.83%), urinary tract infection (1.09%), and surgical site infection (SSI) (0.87%) being the most common. The prevalence of device-associated HAIs was 0.91%. <i>Staphylococcus aureus</i> (17.3%), <i>Escherichia coli</i> (17.1%), and <i>Klebsiella pneumoniae</i> (7.2%) were the primary pathogens in 433 organisms; 29.6% of the <i>Enterobacterales</i> identified showed resistance to third-generation cephalosporins. Pneumonia was the most prevalent HAI in small-to-large hospitals (1.69%-2.34%) and SSI, in extra-large hospitals (over 800 beds, 1.37%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study offers vital insights into the epidemiology of HAIs in hospitals in Japan. These findings underscore the need for national-level PPSs to capture broader epidemiological trends, particularly regarding healthcare challenges post-COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morioka</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0299-040X</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Nagoya University Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koizumi</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Wakayama Medical University, Wakayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oka</LastName><ForeName>Keisuke</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7778-024X</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Nagoya University Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Antimicrobial Stewardship Team, Kariya Toyota General Hospital, Kariya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okudaira</LastName><ForeName>Masami</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Anjo Kosei Hospital, Anjo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomita</LastName><ForeName>Yuka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kojima</LastName><ForeName>Yumi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0005-7818-4748</Identifier><AffiliationInfo><Affiliation>Infection Control Team, Nagoya Ekisaikai Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watariguchi</LastName><ForeName>Toshitaka</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine, Toyota Kosei Hospital, Toyota, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watamoto</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Hematology, Komaki City Hospital, Komaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mutoh</LastName><ForeName>Yoshikazu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Tosei General Hospital, Seto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuji</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Okazaki City Hospital, Okazaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokota</LastName><ForeName>Manabu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Handa City Hospital, Handa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Junichi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1204-1371</Identifier><AffiliationInfo><Affiliation>Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Chihiro</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Nagoya City University East Medical Center, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwata</LastName><ForeName>Susumu</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0007-0562-5535</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Kasugai Municipal Hospital, Kasugai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagaoka</LastName><ForeName>Masatoshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Nagoya Memorial Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Yuji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Sougo Daiyukai Hospital, Ichinomiya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawasaki</LastName><ForeName>Shohei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Nishichita General Hospital, Tokai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Toyota Memorial Hospital, Toyota, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitagawa</LastName><ForeName>Yuichi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infection Control, National Center for Geriatrics and Gerontology, Obu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goto</LastName><ForeName>Takuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, NHO Nagoya Medical Center, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nozaki</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Tokoname Municipal Hospital, Tokoname, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akita</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Infection Control Team, Nagoya City University West Medical Center, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Shinsuke</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infection Control Team, Kamiiida Daiichi Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nozawa</LastName><ForeName>Masanori</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Chita Kosei Hospital, Chita, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Munehiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Japan Organization of Occupational Health and Safety, Asahi Rosai Hospital, Owariasahi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishihara</LastName><ForeName>Masamitsu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Holy Spirit Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Kenta</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Aichi Children's Health and Medical Center, Obu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yagi</LastName><ForeName>Tetsuya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0655-1615</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Nagoya University Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Research Group of Aichi Point Prevalence Survey</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Infect Control Hosp Epidemiol</MedlineTA><NlmUniqueID>8804099</NlmUniqueID><ISSNLinking>0899-823X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39376205</ArticleId><ArticleId IdType="doi">10.1017/ice.2024.130</ArticleId><ArticleId IdType="pii">S0899823X24001302</ArticleId></ArticleIdList></PubmedData></PubmedArticle>